Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shamir R Mehta

Showing results (151-160 of 212) with videos related to

Pageof 22
Sort By:
Journal of the American Heart Association|April 20, 2017
Smokers and Postcessation Weight Gain After Acute Coronary SyndromePayam Dehghani, Bettina Habib, Sarah B Windle, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 9, 2022
Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trialShamir R Mehta, Guillaume Pare, Eva M Lonn, et al.
Circulation. Cardiovascular Interventions|September 19, 2023
Complete Revascularization Versus Culprit-Lesion-Only PCI in STEMI Patients With Diabetes and Multivessel Coronary Artery Disease: Results From the COMPLETE TrialZardasht Oqab, Vijay Kunadian, David A Wood, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|October 19, 2017
Duration of dual antiplatelet therapy and associated outcomes following percutaneous coronary intervention for acute myocardial infarction: contemporary practice insights from the Canadian Observational Antiplatelet StudyJuan J Russo, Shaun G Goodman, Akshay Bagai, et al.
The New England Journal of Medicine|May 22, 2009
Early versus delayed invasive intervention in acute coronary syndromesShamir R Mehta, Christopher B Granger, William E Boden, et al.
Journal of the American College of Cardiology|May 14, 2021
Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI TrialsLawrence A Leiter, Deepak L Bhatt, Darren K McGuire, et al.
Circulation|August 29, 2022
Effects on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: Meta-Analysis of Individual Patient Data From 7 Multicenter Randomized Clinical TrialsGiuseppe Gargiulo, Daniele Giacoppo, Sanjit S Jolly, et al.
JACC. Clinical Electrophysiology|February 4, 2025
Tricuspid Transcatheter Edge-to-Edge Repair in Patients With Transvalvular CIED Leads: The TRILUMINATE Pivotal TrialHursh Naik, Matthew J Price, Samir Kapadia, et al.
International Journal of Cardiology|November 22, 2016
Longitudinal treatment patterns with ADP receptor inhibitors after myocardial infarction: Insights from the Canadian Observational AntiPlatelet sTudyAkshay Bagai, Tracy Y Wang, Shaun G Goodman, et al.
The New England Journal of Medicine|September 3, 2019
Ticagrelor in Patients with Stable Coronary Disease and DiabetesP Gabriel Steg, Deepak L Bhatt, Tabassome Simon, et al.
Pageof 22

Showing results (151-160 of 212) with videos related to

Sort By:
Pageof 22
Journal of the American Heart Association|April 20, 2017
Smokers and Postcessation Weight Gain After Acute Coronary SyndromePayam Dehghani, Bettina Habib, Sarah B Windle, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 9, 2022
Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trialShamir R Mehta, Guillaume Pare, Eva M Lonn, et al.
Circulation. Cardiovascular Interventions|September 19, 2023
Complete Revascularization Versus Culprit-Lesion-Only PCI in STEMI Patients With Diabetes and Multivessel Coronary Artery Disease: Results From the COMPLETE TrialZardasht Oqab, Vijay Kunadian, David A Wood, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|October 19, 2017
Duration of dual antiplatelet therapy and associated outcomes following percutaneous coronary intervention for acute myocardial infarction: contemporary practice insights from the Canadian Observational Antiplatelet StudyJuan J Russo, Shaun G Goodman, Akshay Bagai, et al.
The New England Journal of Medicine|May 22, 2009
Early versus delayed invasive intervention in acute coronary syndromesShamir R Mehta, Christopher B Granger, William E Boden, et al.
Journal of the American College of Cardiology|May 14, 2021
Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI TrialsLawrence A Leiter, Deepak L Bhatt, Darren K McGuire, et al.
Circulation|August 29, 2022
Effects on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: Meta-Analysis of Individual Patient Data From 7 Multicenter Randomized Clinical TrialsGiuseppe Gargiulo, Daniele Giacoppo, Sanjit S Jolly, et al.
JACC. Clinical Electrophysiology|February 4, 2025
Tricuspid Transcatheter Edge-to-Edge Repair in Patients With Transvalvular CIED Leads: The TRILUMINATE Pivotal TrialHursh Naik, Matthew J Price, Samir Kapadia, et al.
International Journal of Cardiology|November 22, 2016
Longitudinal treatment patterns with ADP receptor inhibitors after myocardial infarction: Insights from the Canadian Observational AntiPlatelet sTudyAkshay Bagai, Tracy Y Wang, Shaun G Goodman, et al.
The New England Journal of Medicine|September 3, 2019
Ticagrelor in Patients with Stable Coronary Disease and DiabetesP Gabriel Steg, Deepak L Bhatt, Tabassome Simon, et al.
Pageof 22